Josef Birkmann
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 15
- Oncology 20
- CAR-T cell therapy research 6
- Co-authors
- Martin Wilhelm (15 shared papers)Manfred Smetak (16 shared papers)Kerstin Schaefer‐Eckart (4 shared papers)Volker Kunzmann (6 shared papers)Hermann Einsele (7 shared papers)Brigitte Kimmel (4 shared papers)Timm Hoeres (4 shared papers)Peter Martus (4 shared papers)
- Journals
- Blood (5 papers)Annals of Hematology (5 papers)Annals of Oncology (4 papers)Bone Marrow Transplantation (3 papers)Chemotherapy (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Josef Birkmann
48 papers receiving 1.7k citations
Josef Birkmann's Hit Papers
Peers
Comparison fields: 5 of 97
- Pathology and Forensic Medicine 740
- Genetics 380
- Oncology 772
- Immunology 464
- Neurology 306
Countries citing papers authored by Josef Birkmann
This map shows the geographic impact of Josef Birkmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Birkmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Birkmann more than expected).
Fields of papers citing papers by Josef Birkmann
This network shows the impact of papers produced by Josef Birkmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Birkmann. The network helps show where Josef Birkmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Josef Birkmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network Hit paper breakdown → | 2016 | 313 |
| 2 | 2014 | 129 | |
| 3 | 2012 | 122 | |
| 4 | 2002 | 113 | |
| 5 | 2006 | 113 | |
| 6 | 2018 | 74 | |
| 7 | 2012 | 71 | |
| 8 | 2006 | 69 | |
| 9 | 1997 | 64 | |
| 10 | 2016 | 62 | |
| 11 | 2016 | 59 | |
| 12 | 1984 | 49 | |
| 13 | 2006 | 47 | |
| 14 | 2004 | 47 | |
| 15 | 2012 | 44 | |
| 16 | 2006 | 39 | |
| 17 | 2002 | 38 | |
| 18 | 1999 | 34 | |
| 19 | 1997 | 32 | |
| 20 | 2018 | 30 |
About Josef Birkmann
Josef Birkmann is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Hematology and Genetics, having authored 53 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Immune Cell Function and Interaction (9 papers), CAR-T cell therapy research (6 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (740 citations), Genetics (380 citations), Oncology (772 citations), Immunology (464 citations) and Neurology (306 citations). Josef Birkmann has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Martin Wilhelm, Manfred Smetak, Kerstin Schaefer‐Eckart, Volker Kunzmann, Hermann Einsele, Brigitte Kimmel, Timm Hoeres, Peter Martus, Agnieszka Korfel and Kristoph Jahnke. Their work appears in journals such as Blood, Annals of Hematology, Annals of Oncology, Bone Marrow Transplantation and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.